ANIP — ANI Pharmaceuticals Inc · rev $503.5M

ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.

Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.

Use this ANIP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ANIP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ANIP SEC filings page. Lician reads the product cache first so this HTML stays unique to ANI Pharmaceuticals Inc even when a live quote feed is slow.